About Sciensus
Sciensus is a Healthcare company based in United Kingdom founded in 1992 by Charles Walsh, and was acquired by Healthcare at Home in January 2011. Home-based treatment, medication, and health care support are provided. Sciensus has completed 1 acquisition, including Vine Health. Its chief executive, as recorded, is Darryn Gibson. Its website sciensus.com draws about 29 thousand monthly visits. Sciensus offers products and services including Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs. Its focus areas include Home Healthcare. Its legal entity is SCIENSUS PHARMA SERVICES LIMITED. Its competitors include Bluebird Care, Hurdle and CSN Care Group; 1 of its 3 listed competitors has raised funding.
Company details
Sciensus was founded in 1992 in the United Kingdom and operates within the health care sector. Services focused on treatment, medication delivery, and ongoing support are delivered directly to patients homes. Operations emphasize accessibility for chronic conditions and specialized care needs, with a network covering the UK. Leadership includes founder Charles Walsh and CEO Darryn Gibson, guiding the companys expansion in home health solutions.
- Headquarters United Kingdom
- Founders Charles Walsh
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website sciensus.com
- Social LinkedIn X Facebook YouTube
- Acquired by Healthcare at Home (Jan 2011)
- Legal Name Sciensus Pharma Services Limited
- Date of Incorporation 28 Oct, 1992
- Jurisdiction BURTON-ON-TRENT, STAFFORDSHIRE, ENGLAND
- InvestorsVitruvian Partners
& 2 more
- Investments & Acquisitions
- Acquired byHealthcare at Home
(Jan 2011)
Products & Services of Sciensus
Sciensus offers a comprehensive portfolio of products and services, including Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs.
App for patient information access and support services.
App providing personalized interventions for cancer patients.
Programs to enhance patient engagement and treatment adherence.
Apps and channels of Sciensus
its YouTube channel Sciensus has 287 subscribers and 25 videos.
Videos from Sciensus
The most watched videos on Sciensus's YouTube channel, Sciensus (287 subscribers). Click a video to play it here.
More on Sciensus.
Funding Insights of Sciensus
- Total Rounds 3
- Investors Count 2
All 3 funding rounds of Sciensus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2012 | Private Equity Round | β | β | ||
| Feb 2012 | Private Equity Round | β | Vitruvian Partners | β | |
| Oct 2007 | Debt – Conventional | β | β |
3 investors in total: 3 institutional.
Investors in Sciensus
Sciensus has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Vitruvian Partners, Ardian and Sciensus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth equity investments are directed toward expanding startups across sectors. | vitruvianpartners.com | London, United Kingdom | ||
Private investment firm specializing in markets and partnerships. | ardian.com | |||
Sciensus is recognized as a leading life sciences organization focused on patient care. | hah.co.uk | United Kingdom |
Investor details for Sciensus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sciensus
6 people are tracked at Sciensus (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Charles Walsh | Founder | Leadership |
Darryn Gibson | CEO | Leadership |
Jonathan Asbridge | Chief Clinical Officer | Leadership |
Gordon Cox | COO | Leadership |
Richard Blyth | Chief Customer Officer | Leadership |
John Bradshaw | Group Company Secretary | Team |
Complete people profiles for Sciensus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sciensus
Sciensus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vine Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cancer treatment is managed via a social tracking app. | vinehealth.ai | London, United Kingdom | 2018 | Jan 2024 | β’β’β’β’ |
Complete acquisition details for Sciensus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sciensus
5 dated milestones of Sciensus across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Sciensus is founded.
- Funding First funding round.
- Exit Acquired by Healthcare at Home.
- Funding Latest funding round, Private Equity Round,.
- Acquisition Acquires Vine Health.
Competitors of Sciensus
Sciensus has 3 listed competitors in our database, 1 of them funded. They include Bluebird Care, Hurdle and CSN Care Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bluebirdcare.co.uk | 2004 | Waterlooville, United Kingdom | Provider of home care and support services | |||
| hurdle.bio | 2017 | London, United Kingdom | 28 | Home diagnostic testing services are offered by Hurdle. | ||
| csncare.co.uk | 2019 | Milton Keynes, United Kingdom | $5.48M | Diversified home health care services are provided across the UK. |
Detailed competitors of Sciensus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sciensus
The website of Sciensus (sciensus.com) receives about 28.8K visits a month.
- Monthly visits28.8K
▼ 3% vs previous month
Websites whose visitors overlap most with Sciensus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hah.co.uk | 100% | View details | |||
healthinformaticsforum.com | healthinformaticsforum.com | 78% | β | ||
informatica2009.sld.cu | informatica2009.sld.cu | 78% | β | ||
amorphous.com.my | amorphous.com.my | 78% | β | ||
| clevelandcliniclondon.uk | 53% | #272,329 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 9 similar websites and full traffic analytics for Sciensus
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sciensus
Complete news archive for Sciensus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sciensus
Sciensus was founded in 1992 and raised its 1st funding round 15 years after it was founded.
Sciensus is headquartered in United Kingdom.
Darryn Gibson is the CEO of Sciensus, as recorded in our data.
Sciensus was founded in 1992 in the United Kingdom and operates within the health care sector. Services focused on treatment, medication delivery, and ongoing support are delivered directly to patients homes. Operations emphasize accessibility for chronic conditions and specialized care needs, with a network covering the UK. Leadership includes founder Charles Walsh and CEO Darryn Gibson, guiding the companys expansion in home health solutions.
Sciensus's top competitors include Hurdle, Bluebird Care and CSN Care Group.
Sciensus offers Sciensus Intouch App, Sciensus Cancer Companion App, and Patient Support Programs.
Sciensus has made 1 acquisition, including Vine Health.
Sciensus has 3 investors. Key investors include Vitruvian Partners, Ardian, and Sciensus.
Sciensus operates through Sciensus Pharma Services Limited.
Yes. Sciensus was acquired by Healthcare at Home in January 2011.

